Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dariusz Stencel"'
Publikováno v:
Acta Poloniae Pharmaceutica, Vol 81, Iss 1, Pp 187-196 (2024)
All tasks performed by hospital pharmacies concern the management of medicinal products. The aim of this work is to analyze the functioning and implemen-tation costs of unit-dose and multi-dose automatic drug distribution systems in comparison with t
Externí odkaz:
https://doaj.org/article/bd26090ef4564efb94ec09093cd2ac3f
Publikováno v:
Polish Journal of Cardio-Thoracic Surgery. 2:145-150
Lung cancer is the most common malignant neoplasm diagnosed worldwide. In Poland, in 2011, lung cancer was diagnosed in 14,522 men and 6,283 women. Morbidity and mortality are nearly equal, and lung cancer is still the most common cause of cancer-rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c69506b32a04b18ba308dbed8262975c
https://doi.org/10.5114/kitp.2014.43841
https://doi.org/10.5114/kitp.2014.43841
Autor:
Marcin Nicoœ, Radosław Mlak, P. Krawczyk, B. Jarosz, Beata Pająk, Marek Sawicki, Dariusz Stencel, Janusz Milanowski, Tomasz Trojanowski, Krzysztof Kucharczyk, Tomasz Powrózek
Publikováno v:
Oncology Letters; Vol
The HER2 (ErbB2/neu) protein is a member of the HER (ErbB) receptor family (EGFR, HER2, HER3 and HER4) that expresses tyrosine kinase activity in the intracellular domain. EGFR and HER2 overexpression is observed in numerous types of cancer, neverthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8db38909aa539590454ea0ae9d4eb67
https://doi.org/10.3892/ol.2013.1495
https://doi.org/10.3892/ol.2013.1495
Autor:
Bożena Jarosz, Dariusz Stencel, Tomasz Powrózek, Marek Sawicki, Kamila Wojas-Krawczyk, Janusz Milanowski, Paweł Krawczyk, Radosław Mlak, Tomasz Trojanowski
Publikováno v:
Pathology Oncology Research
The time-limited efficacy of reversible EGFR-TKIs in patients with advanced non-small cell lung cancer (NSCLC) with EGFR gene activating mutations is associated with development of treatment resistance after some period of therapy. This resistance pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bab8b1d9d8393e3e39ace5841bf81ec
https://pubmed.ncbi.nlm.nih.gov/24789720
https://pubmed.ncbi.nlm.nih.gov/24789720
Autor:
Paweł, Krawczyk, Marcin, Nicoœ, Tomasz, Powrózek, Radosław, Mlak, Marek, Sawicki, Bożena, Jarosz, Beata, Pająk, Krzysztof, Kucharczyk, Dariusz, Stencel, Tomasz, Trojanowski, Janusz, Milanowski
Publikováno v:
Oncology Letters
The HER2 (ErbB2/neu) protein is a member of the HER (ErbB) receptor family (EGFR, HER2, HER3 and HER4) that expresses tyrosine kinase activity in the intracellular domain. EGFR and HER2 overexpression is observed in numerous types of cancer, neverthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b71d4b9ddf800c660422086624f731bc
https://pubmed.ncbi.nlm.nih.gov/24137465
https://pubmed.ncbi.nlm.nih.gov/24137465
Autor:
Bernarda, Kazanowska, Agata, Mikołajewska, Anna, Balcerska, Walentyna, Balwierz, Jerzy, Bodalski, Agnieszka, Dłuzniewska, Elzbieta, Drozyńska, Andrzej, Kurylak, Adam, Reich, Dariusz, Stencel, Beata, Szewczyk, Jacek, Wachowiak, Mariusz, Wysocki, Alicja, Chybicka
Publikováno v:
Medycyna wieku rozwojowego. 8(4 Pt 2)
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children younger then 15 years of age. The treatment of RMS localized in bladder or prostate still remains controversial. The aim of this study was analysis of treatment results in chil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4eae1cf1f2e200f4c3176b12d97c7a36
https://pubmed.ncbi.nlm.nih.gov/15951604
https://pubmed.ncbi.nlm.nih.gov/15951604